Text this: A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)

 _____       ___      _  _     _____     ______  
|  __ \\    / _ \\   | \| ||  |  ___||  /_____// 
| |  \ ||  / //\ \\  |  ' ||  | ||__    `____ `  
| |__/ || |  ___  || | .  ||  | ||__    /___//   
|_____//  |_||  |_|| |_|\_||  |_____||  `__ `    
 -----`   `-`   `-`  `-` -`   `-----`   /_//     
                                        `-`